CLINICAL_TRIALS
trial_result
· 2014-05-09
Clinical Trial Update: Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder. [Phase 3]
Summary
A Phase 3 study evaluating the safety and efficacy of GABITRIL for adults with Generalized Anxiety Disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cephalon | Conditions: Anxiety Disorders | Phase 3 | Status: COMPLETED